San Francisco, CA, United States of America

Birgit K Jaitner

This inventor holds 1 USPTO granted patent. Top assignee: Chiron Corporation. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Birgit K Jaitner. Retrieved from https://idiyas.com/inventor/birgit-k-jaitner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Birgit K Jaitner: Innovator in Cancer Research

Introduction

Birgit K Jaitner is a notable inventor based in San Francisco, CA. She has made significant contributions to the field of cancer research, particularly through her work on Sos1 inhibitors. Her innovative approach has the potential to impact the treatment of tumor cell growth.

Latest Patents

Birgit K Jaitner holds 1 patent related to her research. The patent focuses on inhibitors of human Sos1, including antisense oligonucleotides, methods, and compositions specific for human Sos1. These methods are designed to modulate Sos1 expression and regulate cell growth, especially in tumor cells.

Career Highlights

Jaitner is associated with Chiron Corporation, where she has been instrumental in advancing research in her area of expertise. Her work has garnered attention for its potential applications in therapeutic settings.

Collaborations

One of her notable collaborators is Wendy Fantl, who has worked alongside Jaitner in her research endeavors. Their partnership highlights the importance of teamwork in scientific innovation.

Conclusion

Birgit K Jaitner's contributions to cancer research through her innovative work on Sos1 inhibitors exemplify the impact of dedicated inventors in the field. Her ongoing research continues to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…